• MSR80 AI-Enabled Risk of Bias Assessment of RCTs in Systematic Reviews: A Case Study

    Dec 1, 2023, 00:00

  • HPR157 Challenges and Potential Solutions in Implementing a Bundle Payment Program for Osteoarthritis

    Dec 1, 2023, 00:00

  • HSD92 Factors Having an Impact on the Prescription of Cancer Treatments in Hospital at Home Program in Bronchopulmonary Cancer: A French Claims Database Analysis (2016-2021)

    Dec 1, 2023, 00:00

  • MT56 Beyond the Hype - Economic Evaluation and Artificial Intelligence Maturity Level in Healthcare

    Dec 1, 2023, 00:00

  • P18 Adjusted Comparison of Teclistamab Versus Real-World Physician’s Choice (RWPC) of Therapy in Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

    Dec 1, 2023, 00:00

  • OP27 Observations of Patient Preference in the Creation of Treatment Support Materials

    Dec 1, 2023, 00:00

  • PCR240 Incorporating a Holistic Patient Perspective When Assessing the Value of Non-Small Cell Lung Cancer (NSCLC) Therapies

    Dec 1, 2023, 00:00

  • SA40 Patient-Level Simulation Models in Cancer Care

    Dec 1, 2023, 00:00

  • PT22 Exploring Reimbursement Disparities: A Comparative Study of Pharmaceutical Access in Hong Kong and Mainland China

    Dec 1, 2023, 00:00

  • HPR97 Healthcare Systems Resilience and the COVID-19 Emergency: How Care Can Be Improved Within the Current Budget and Resources Constraint by Increasing the Efficiency of Healthcare Delivery

    Dec 1, 2023, 00:00

  • EE489 Healthcare Utilization and Costs Among Treatment-Experienced Medicaid Beneficiaries Utilizing Single-Treatment Versus Multi-Treatment Regimens for HIV

    Dec 1, 2023, 00:00

  • SA75 The Use of Formal Expert Opinion Elicitation to Inform Model Structure and Inputs in Rare Diseases

    Dec 1, 2023, 00:00

  • EE147 "I'll Live Less, You'll Live Better, Let's Make It Count": A Qualitative Exploration of Drivers Barriers for Sacrificing Remaining Life Expectancy to Restore Relatives to Full Health in Time Trade Off Exercises

    Dec 1, 2023, 00:00

  • EE614 Evaluating the Cost-Effectiveness of CYP2C19 Genetic Testing in Patients Who Have Experienced an Ischaemic Stroke or Transient Ischaemic Attack in England and Wales

    Dec 1, 2023, 00:00

  • RWD59 Economic and Healthcare Resource Utilization by Transthyretin Amyloid Cardiomyopathy Patients in Spain: Observations From the PRACTICA Study

    Dec 1, 2023, 00:00

  • HTA333 A Systematic Review of Robotic-Assisted Surgery in Esophageal Cancer: Comparison with Open Esophagectomy

    Dec 1, 2023, 00:00

  • SA58 Approaches to Examine Treatment Adherence and Persistence Using German Claims Data: An Exemplary Analysis Using Oral Therapies for Prostate Cancer

    Dec 1, 2023, 00:00

  • MSR7 Incorporating External Data to Inform Overall Survival Extrapolation: A Review of NICE Health Technology Appraisals for Oncology Drugs

    Dec 1, 2023, 00:00

  • PCR62 Treatment Satisfaction and Health-Related Quality of Life in People Living With HIV Receiving DTG/3TC Who Are Treatment Experienced or Treatment Naive in Europe

    Dec 1, 2023, 00:00

  • EE91 A Systematic Literature Review of Health-Related Quality of Life, Costs, and Healthcare Resource Use in Primary Biliary Cholangitis

    Dec 1, 2023, 00:00

  • RWD108 Real-World Data and Real-World Evidence Terminology Harmonization: Evidence Gaps and Future Steps

    Dec 1, 2023, 00:00

  • EPH143 Health Behavior and Quality of Life in Women With Endometriosis

    Dec 1, 2023, 00:00

  • RWD18 Characterization of Time-to-Treatment-Discontinuation (TTTD) as a Proxy for Progression-Free Survival (PFS) in Real-World Evidence (RWE) Based Analyses of Relapsed-Refractory Multiple Myeloma (RRMM)

    Dec 1, 2023, 00:00

  • HTA229 PICO Criteria Applied in Joint Action 3 Differ From National HTA Requirements: A Review of Oncology Drug Assessments in Denmark, France, Germany, and Sweden

    Dec 1, 2023, 00:00

  • EPH190 Clinical Characteristics and Treatment Patterns of Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Mexico

    Dec 1, 2023, 00:00

  • MSR148 Methodological Aspects of Composite Measures: A Comparison of Techniques for Rescaling and Aggregation

    Dec 1, 2023, 00:00

  • HPR161 HTA and Economic Evaluations for a Genomic Strategy in Italy

    Dec 1, 2023, 00:00

  • EPH239 Incremental Cost Burden of Major Depressive Disorder in Patients with Rheumatoid Arthritis in Korea

    Dec 1, 2023, 00:00

  • HSD123 Environmental Impact of Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in the Netherlands

    Dec 1, 2023, 00:00

  • PCR151 Health Related Quality of Life (HRQOL) Among Patients with Transthyretin Amyloidosis (ATTR): A Systematic Literature Review

    Dec 1, 2023, 00:00

  • EE657 Health Resource Utilization by Disease Stage for People with Amyotrophic Lateral Sclerosis (pALS) in the French National Health Data System (SNDS)

    Dec 1, 2023, 00:00

  • EE567 Economic Evaluations of Pharmacological Interventions for Lupus Population – a Targeted Literature Review

    Dec 1, 2023, 00:00

  • RWD44 Utilization of Short-Term and Long-Term Disability, and Workers' Compensation in Employees with Major Depressive Disorder Compared with Employed Controls

    Dec 1, 2023, 00:00

  • RWD83 Epidemiological Characterization of the Current Patient Population of Multiple Sclerosis Patients Enrolled in a Patient Registry for Interferon-Beta 1a SC in Portugal

    Dec 1, 2023, 00:00

  • EE457 Cost-Effectiveness Analysis of Patiromer in Heart Failure Patients with Reduced Ejection Fraction for the Treatment of Hyperkalemia: Analysis of the Diamond Clinical Trial

    Dec 1, 2023, 00:00

  • HPR106 New Proposed European Commission Pharmaceutical Regulation – Potential Changes and Impact on Manufacturers With a Focus on Eastern Southern European Member States

    Dec 1, 2023, 00:00

  • MT37 Clinical Utility of Circulating Tumor Cell (CTC) Enumeration-Based Liquid Biopsy and HER2 CTC Assessment in Patients with Metastatic Breast Cancer: Overview of Current Available Data and Interventional Trials

    Dec 1, 2023, 00:00

  • EE643 Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 PCR Screening: A Cost-Utility Analysis

    Dec 1, 2023, 00:00

  • HTA144 NICE Value Male Lives More Than Female Lives?

    Dec 1, 2023, 00:00

  • PCR5 First Interim Analysis of Patient-Reported Outcomes in View Study: A Multicenter, Single-Arm, Prospective, Non-Interventional Study of Vonoprazan in Real-World Clinical Practice in China

    Dec 1, 2023, 00:00

  • MSR153 Can ChatGPT Generate Synthetic Data to Train Systematic Literature Review Machine Learning Models?

    Dec 1, 2023, 00:00

  • SA28 Evaluation of Disease Epidemiology, Comorbidities, Treatment Patterns, and Healthcare Resource Utilization of Alopecia Areata in United Arab Emirates: A Retrospective Claims Database Study

    Dec 1, 2023, 00:00

  • HTA89 An Increased Use of External Data to Inform Survival Extrapolations in NICE Technology Appraisals

    Dec 1, 2023, 00:00

  • MT76 DiMe Library of Digital Endpoints: Strengths, Weaknesses, and Pathways for Improvement in Digital Health Research

    Dec 1, 2023, 00:00

  • EE128 Budget Impact of the Jada System for the Treatment of Patients with Abnormal Post-Partum Bleeding or Hemorrhage in the United States

    Dec 1, 2023, 00:00

  • EPH166 Access Trends to Cardiac Implantable Electronic Devices in the Brazilian Public Healthcare System: A Twelve-Year Real World Data Analysis

    Dec 1, 2023, 00:00

  • PCR57 A Qualitative Interview Study to Evaluate Single-Tablet Combination Therapy (STCT) Within a Phase 3 Pulmonary Arterial Hypertension (PAH) Clinical Trial – Interim Analysis

    Dec 1, 2023, 00:00

  • EPH115 Primary Prevention Strategies for Stroke: A Multilevel Approach

    Dec 1, 2023, 00:00

  • RWD173 Chronification in the Use of Benzodiacepines: Incidence Stratified by Sex and Age Groups

    Dec 1, 2023, 00:00

  • EE29 Clinical and Economic Impact of Pre-Exposure Prophylaxis With Tixagevimab+Cilgavimab in 2022 in Switzerland to Protect Immunocompromised Individuals

    Dec 1, 2023, 00:00

  • MSR144 The Impact of Enhanced Access to Modern Antineoplastic Drugs for Breast Cancer Treatment on Mortality and Economic Development

    Dec 1, 2023, 00:00

  • CO128 Health-Related Quality of Life in Generalized Myasthenia Gravis- the Relationship between MG-ADL and EQ-5D-5L in the Raise Study

    Dec 1, 2023, 00:00

  • EE649 Cost Per Responder of Bimekizumab Against Il-17A, IL-12/23 and IL-23 Inhibitors in the Treatment of Psoriatic Arthritis in Sweden

    Dec 1, 2023, 00:00

  • PCR84 The Daily Life and Psychosocial Impacts of Friedreich Ataxia: A Qualitative Study of Patient Lived Experiences

    Dec 1, 2023, 00:00

  • HTA269 Are We Leaving No One behind? Health Technology Assessment as a Pathway to Social Justice

    Dec 1, 2023, 00:00

  • EE152 The Implicit Devaluation of Health Benefits Over Time in NICE Decision-Making Criteria: Assessing NICE’s Static Willingness to Pay Threshold in the Context of Inflation.

    Dec 1, 2023, 00:00

  • EE582 Actuarial Value Chain Modelling of Valoctocogene Roxaparvovec (VALROX) Therapy for Hemophilia A: An Adaptation from ICER Final Evidence Report*

    Dec 1, 2023, 00:00

  • EE72 A Cost-Effectiveness Analysis of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-Small Cell Lung Cancer in Portugal

    Dec 1, 2023, 00:00

  • HTA109 A Review of the Use of Indirect Treatment Comparisons to Support Health Technology Assessments in Ireland

    Dec 1, 2023, 00:00

  • PCR228 Among European Individuals with Major Depressive Disorder, Higher Severity of Insomnia Symptoms Is Independently Associated with Poorer Health-Related Outcomes

    Dec 1, 2023, 00:00

  • EE742 The Comparative Healthcare Cost between Robotic Esophagectomy and Video-Assisted Esophagectomy for Esophageal Cancer in Japan

    Dec 1, 2023, 00:00

  • EE646 Waiting Times and Cost-Effectiveness: An Early Case Study in Cognitive Behavioral Therapy for Anxiety

    Dec 1, 2023, 00:00

  • EPH269 Estimating the Burden of Vaccine-Preventable Infectious Diseases Caused by Herpesviruses Beyond Herpes Zoster in Europe: What's Going on in Spain and Germany?

    Dec 1, 2023, 00:00

  • MSR150 Artificial Intelligence (AI) in Performing Landscape Review and Linguistic Analysis for Curative Intent in Prostate Cancer (PC)

    Dec 1, 2023, 00:00

  • EE496 Botulinum Toxin Type a for the Treatment of Focal Spasticity in Children with Cerebral Palsy in Thailand: A Cost-Utility Analysis

    Dec 1, 2023, 00:00

  • EE302 Value of End-of-Life Health Gains

    Dec 1, 2023, 00:00

  • PCR19 The EU Patient Community's Perspectives on Data Protection and Data Control

    Dec 1, 2023, 00:00

  • HPR104 A Review of Biosimilar Utilization across EU4 and UK Since the Introduction of the First Biosimilar

    Dec 1, 2023, 00:00

  • CO93 Matching-Adjusted Indirect Treatment Comparison (MAIC) of Teclistamab Versus Selinexor-Dexamethasone for the Treatment of Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

    Dec 1, 2023, 00:00

  • EE335 Burden of COVID-19 Related Hospitalization in Adults at High Risk for Severe Disease Progression in Germany—A Retrospective Claims Data Analysis

    Dec 1, 2023, 00:00

  • HTA154 Trends of Indirect Treatment Comparison Methods Use in NICE Technology Appraisals for Haematologic Cancers

    Dec 1, 2023, 00:00

  • EE357 Cost per Responder Analysis Comparing Adagrasib and Sotorasib in Patients With KRAS G12C-Mutated Previously Treated Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2023, 00:00

  • EE320 Impact of NASH Disease Model Adjustment to New Literature Findings: Assessing Cost-Effectiveness of Actual and Theoretical Treatments

    Dec 1, 2023, 00:00

  • PT27 How Much Does TLV Value Rarity? A Review of Reimbursement Decisions on Orphan Drugs in Sweden from 2017 through 2022

    Dec 1, 2023, 00:00

  • HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece

    Dec 1, 2023, 00:00

  • EE23 Cost Utility Analysis of Once-Weekly Semaglutide and Dulaglutide for Patients With Type 2 Diabetes in Saudi Arabia

    Dec 1, 2023, 00:00

  • CO75 Non-Pharmacological Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Comprehensive Review

    Dec 1, 2023, 00:00

  • HTA304 The Impact of Different HTA Frameworks on Time to Patient Access: A Case Study Assessing the First Commercial Launch Indications for Lynparza, Tagrisso, Imfinzi, Calquence and Enhertu

    Dec 1, 2023, 00:00

  • EPH5 Prevalence and Predictive Factors of Severe Coronary Lesions in Algerian Patients Undergoing Coronary Angiography

    Dec 1, 2023, 00:00

  • EE527 The Indirect Costs and Burden of Vaccine Preventable Cancers Mortality in Middle East and North Africa (MENA) Countries

    Dec 1, 2023, 00:00

  • EE533 Healthcare Resource Utilization (HCRU) and Related Direct Healthcare Costs for Patients with Metastatic Urothelial Cancer (mUC): Findings from a Retrospective Observational Cohort Study in a Clinical Practice Setting in Italy

    Dec 1, 2023, 00:00

  • PCR107 (How) Should Cost-Effectiveness Analysis Accommodate Heterogeneity in Patient Preferences?

    Dec 1, 2023, 00:00

  • SA81 Has the Publication of China Guidelines for Pharmacoeconomic Evaluations 2020 influenced the Study Quality of Economic Evaluations in China? A Systematic Review

    Dec 1, 2023, 00:00

  • MT63 Value Assessment of Combination Digital Health Technologies Under New NICE Evidence Standards Framework: Evidence Submitted and Key Factors for Positive Recommendation

    Dec 1, 2023, 00:00

  • EPH264 The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Adults Aged 60 and Older in Italy: Preliminary Results of a Markov Model Analysis

    Dec 1, 2023, 00:00

  • RWD157 Assessment of Real-World Treatment Patterns and Healthcare Resource Utilization (HCRU) in Patients with Lenalidomide-Refractory Relapsed/Refractory Multiple Myeloma (RRMM) from the US Optum Database

    Dec 1, 2023, 00:00

  • HTA62 A Systematic Review of the New NICE Highly Specialised Technologies Criteria: How Do NICE Judge Criteria 3 and 4 to be Met?

    Dec 1, 2023, 00:00

  • MSR2 Development of an Algorithm to Identify the Type of Diabetes in the French Administrative Health Care Database “Système National Des Données De Santé” (SNDS)

    Dec 1, 2023, 00:00

  • HPR101 Maximizing the Quality of Comparative Evidence in Externally Controlled Studies—The Need for a Unified Framework

    Dec 1, 2023, 00:00

  • RWD38 Implement a Direct-to-Patient Application to Recruit Diverse Patients and Collect Real-World Data

    Dec 1, 2023, 00:00

  • EE95 Cost-Effectiveness Analysis of Pemigatinib for the Treatment of Adult Patients with Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement That Have Progressed After Systemic Therapy in Greece

    Dec 1, 2023, 00:00

  • HPR192 Does Including Biosimilars Earlier in the Treatment Pathways Lead to Cost Savings in Rheumatology?

    Dec 1, 2023, 00:00

  • HPR127 Corporate Social Responsibility in Health Technology Industry, in Greece

    Dec 1, 2023, 00:00

  • PCR249 Quality of Life of Moroccan Children with Rare Diseases: Evidence from Real-World Data

    Dec 1, 2023, 00:00

  • MSR109 Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment: Case-Study on Bevacizumab

    Dec 1, 2023, 00:00

  • MT30 Coverage and Payment Implications for Breakthrough Medical Devices Following Translational Coverage of Emerging Technologies (TCET) Proposed Rule in the US

    Dec 1, 2023, 00:00

  • MSR10 Incidence, Prevalence, and Clinical Characteristics of Patients with Chronic Lymphocytic Leukemia (CLL) in Spain: Natural Language Processing (NLP) Analysis of Electronic Health Records (EHRs)

    Dec 1, 2023, 00:00

  • EE28 Cost-Effectiveness Formulation of PCR-Test Screening for COVID-19 Regarding Multiple Factors in Epidemic

    Dec 1, 2023, 00:00

  • Epidemiology Public Health

    Dec 1, 2023, 00:00

  • MSR28 Examining Guidance and Key Principles for Conducting Living Systematic Reviews: A Methods Review

    Dec 1, 2023, 00:00

  • EE192 The Cost-Effectiveness of a Bimekizumab Versus Secukinumab Treatment Pathway in Patients with Active Axial Spondyloarthritis in Scotland

    Dec 1, 2023, 00:00

  • PCR200 Characteristics at Baseline of Patients with Asthma and Prior Systemic Corticosteroid Use Initiating Dupilumab Enrolled in the Real-World Study Rapid

    Dec 1, 2023, 00:00

  • HTA343 Machine Learning Prediction of Drug Overdoses Among Young People

    Dec 1, 2023, 00:00

  • PCR161 Population Norms for the SF-36 Health Status Measure in Hungary

    Dec 1, 2023, 00:00

  • HPR73 Underfunding of Public Health System and Unmet Dental Needs Among the European Elderly Population

    Dec 1, 2023, 00:00

  • EPH217 Discriminant Validity of EQ-5D-Y-3L Between Children-Reported Health-Related Quality of Life and Parent-Reported Developmental Disabilities

    Dec 1, 2023, 00:00

  • SA11 A Systematic Review on the Safety and Effectiveness of the Active Middle Ear Implant in the Treatment of Conductive and Mixed Hearing Loss

    Dec 1, 2023, 00:00

  • CO170 Treatment Exposure-Adjusted Event Rates (EAERs) for Grade 3/4 AEs Associated with Emerging and Existing Systemic Therapies for mCRC with at Least 2 Prior Lines of Therapy: Informing Payer and Pathway Formulary Decision Making

    Dec 1, 2023, 00:00

  • EPH51 Artificial Intelligence (AI) Tools for Outbreak Detection and Response: A Transnational Platform for Surveillance, Monitoring and Decision Support

    Dec 1, 2023, 00:00

  • HPR194 New Framework for Early Access to Drugs in Fran Feedback After a One-Year Use in University Public Hospitals of Paris

    Dec 1, 2023, 00:00

  • HSD40 Fecal Incontinence of Patients After Stoma Reversal: A German Claims Data Analysis Reveals Concerns

    Dec 1, 2023, 00:00

  • EE176 Hospitalization Trends for All Intestinal Infectious Diseases Since Introduction of Rotavirus Gastroenteritis (RVGE) Vaccine in Ireland

    Dec 1, 2023, 00:00

  • PCR50 The Adelphi Adherence Questionnaire (ADAQ©): Psychometric Validation of a New Patient Self-Report Measure of Medication Adherence Across Multiple Disease Areas

    Dec 1, 2023, 00:00

  • EE442 An Economic Evaluation of Universal Childhood Varicella Vaccination in Ireland

    Dec 1, 2023, 00:00

  • CO19 Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

    Dec 1, 2023, 00:00

  • PCR169 Prevalence and Predictive Factors of Psychological Distress Among People with Diabetes in France

    Dec 1, 2023, 00:00

  • EE691 Economic Evaluation and Budget Impact of RVd as Induction Regimen Prior to ASCT in Patients with Newly Diagnosed Multiple Myeloma from the Perspective of the Public Health Sector in Mexico

    Dec 1, 2023, 00:00

  • EPH29 Estimating the Incidence and Characteristics of Female Patients in Norway With Early Breast Cancer Who Are at High Risk of Disease Recurrence

    Dec 1, 2023, 00:00

  • EE5 The Health Return on Investment (ROI) Assessor: Evaluating Novel Cardiovascular Disease (CVD) Prevention Approaches in Estonia

    Dec 1, 2023, 00:00

  • EE98 Economic Burden of Patients with Paroxysmal Nocturnal Hemoglobinuria in China

    Dec 1, 2023, 00:00

  • HTA141 Exploring the Role of Patient Experience Data and Patient Involvement in Health Technology Assessment Decision Making

    Dec 1, 2023, 00:00

  • HTA275 Trends in Medical Services Reimbursement Outcomes in Australia: A Novel and Comprehensive Analysis

    Dec 1, 2023, 00:00

  • HTA78 Examining the Influence of Study Design, Incremental Medical Benefit, and Price-Setting Pathway on Pricing of Digital Health Applications in Germany

    Dec 1, 2023, 00:00

  • HPR153 Market Access Strategies for Advanced Therapy Drugs: A Comparative Analysis of the European and American Markets, Authorizations and Withdrawals

    Dec 1, 2023, 00:00

  • EE493 Healthcare Resource Utilization Associated with Major Depressive Disorder with Insomnia Symptoms: A Retrospective Cohort Study in Hungary

    Dec 1, 2023, 00:00

  • EE38 Cost-Effectiveness Analysis of the NEON Intervention for People With Psychosis and Non-Psychosis Mental Health Problems

    Dec 1, 2023, 00:00

  • Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report

    Dec 1, 2023, 00:00

  • EE115 Cost-Effectiveness Analysis of Using Ketoanalogues of Essential Aminoacids in Patients With Chronic Kidney Disease in Kazakhstan

    Dec 1, 2023, 00:00

  • RWD75 An Innovative Data Collection System for Improving Outcomes in Patients Treated with Diabetes Technology

    Dec 1, 2023, 00:00

  • EE654 Occupational Impact of Tardive Dyskinesia: A Cross-Sectional, International Survey Assessing the Perceptions and Experiences of Patients With TD and Physicians Who Treat TD

    Dec 1, 2023, 00:00

  • HTA231 What Is the Psycho-Oncologic (PsyO) Impact of Progression in Patients with Cancer? A Targeted Literature Review (TLR) to Assess the Available Data

    Dec 1, 2023, 00:00

  • EE374 Estimating the Impact of Tumors of the Oesophageal and Gastro-Oesophageal Junction on Work, Leisure and Household Activity Times: Evidence from a Patient Survey in Switzerland

    Dec 1, 2023, 00:00

  • EE360 Clinical and Economic Evaluation of Atezolizumab Versus Durvalumab Administration in Adult Patients with Extensive Stage Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • HPR198 By Any Genes Necessary: Review of Pipeline Developments and Access Hurdles Likely to be Faced By Gene Therapies

    Dec 1, 2023, 00:00

  • RWD63 Clinical Outcomes in Non-Inhibitor Severe Haemophilia A Patients Receiving Prophylaxis Across Currently Available Haemophilia A Treatments: Insights Form the ‘Cost of Haemophilia: A Socioeconomic Survey III’ (CHESS III) Study

    Dec 1, 2023, 00:00

  • RWD131 A Nationwide Feasibility Study and Study Concept to Assess the Burden of Duchenne Muscular Dystrophy (DMD) in Finland

    Dec 1, 2023, 00:00

  • HSD119 Patient Pathways, Genetic Testing, and Diagnosis of X-Linked Retinitis Pigmentosa in Europe: Insights from the Cross-Sectional Explore Xlrp-1.2 Physician Survey

    Dec 1, 2023, 00:00

  • EE293 Estimation of the Cost of the National Immunization Program for Children and Adolescents in Greece

    Dec 1, 2023, 00:00

  • SA82 Systematic Versus Rapid Review: The Impact of Database Coverage and Single Studies Selection on the Review's Conclusions

    Dec 1, 2023, 00:00

  • SA51 Definition and Methodology of Rapid Literature Reviews

    Dec 1, 2023, 00:00

  • RWD148 Using Linked Data: Agreement in Diagnosis for Patients with Asthma or Diabetes

    Dec 1, 2023, 00:00

  • HTA350 Fixed Effect Versus Random Effects Bayesian Network Meta-Analyses in Practi What Is Used to Inform National Institute for Health and Care Excellence (NICE) Technology Appraisals?

    Dec 1, 2023, 00:00

  • PCR238 Measuring the Socioeconomic Impact of Cancer: A Systematic Review and Quality Appraisal of Patient-Reported Outcome (PRO) Instruments

    Dec 1, 2023, 00:00

  • PCR171 Translation and Cross-Cultural Validation of the Chinese Version of Adult Social Care Outcomes Toolkit for Service Users in Hong Kong

    Dec 1, 2023, 00:00

  • EE554 Cost-Effectiveness Analysis of Novoseven® Treatment for Postpartum Hemorrhage in Turkiye

    Dec 1, 2023, 00:00

  • EPH91 The Incidence of Uveitis in the United Kingdom 2004-2021

    Dec 1, 2023, 00:00

  • PCR120 A Psychometric Evaluation of the RAND 36 Scale Among Japanese Adults With Insomnia in 2023

    Dec 1, 2023, 00:00

  • RWD25 Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from EXACOS-CV Studies in Spain, Germany, the Netherlands and Canada

    Dec 1, 2023, 00:00

  • RWD168 Epidemiology of Respiratory Syncytial Virus in Uppsala and Stockholm: A Population-Based Study

    Dec 1, 2023, 00:00

  • RWD62 Dupixam: An SNDS (SYSTÈME NATIONAL DES DONNÉES DE SANTÉ) Study to Characterize Patients Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis in France

    Dec 1, 2023, 00:00

  • HTA216 Analyzing Delays in Economic Appraisal in France : A Comparative Study of 2021 and 2022

    Dec 1, 2023, 00:00

  • EE540 Cost-Effectiveness of Brexucabtagene Autoleucel for the Treatment of Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Patients Aged 26 Years or Older in the United Kingdom

    Dec 1, 2023, 00:00

  • MSR91 What Are Unmet Needs for the Use of Registries in Regulatory/HTA Decision-Making in Europe? A Survey-Based Approach From the More-EUROPA Project

    Dec 1, 2023, 00:00

  • EPH109 Predictors of Individual General Life Satisfaction in the German General Social Survey (ALLBUS) Cohorts from 2010 to 2021

    Dec 1, 2023, 00:00

  • CO35 Clinical Outcomes Associated with Sodium Zirconium Cyclosilicate for Treating Hyperkalaemia in Patients Receiving Haemodialysis

    Dec 1, 2023, 00:00

  • RWD159 Comparison of Livingstone's Estimates of Prevalence of Six Different Rare Blood Cancers with Darwin EU

    Dec 1, 2023, 00:00

  • EPH102 Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) Among Canadian Infants

    Dec 1, 2023, 00:00

  • PCR140 Management of Osteogenesis Imperfecta: Self-Reported Access Challenges to Consumables and Services Across the EU5 and Nordics

    Dec 1, 2023, 00:00

  • HTA36 Monitoring of the Long-Term Impact of the COVID-19 Pandemic on the Decision Process of the Italian Medicine Agency

    Dec 1, 2023, 00:00

  • HPR10 Added Benefit and Revenues of Oncology Drugs Approved By the European Medicines Agency between 1995 and 2020

    Dec 1, 2023, 00:00

  • EPH229 Hospitalization Patterns and Costs of Primary Biliary Cholangitis (PBC) in Germany

    Dec 1, 2023, 00:00

  • HSD17 Key Features and Preferences for New High-Volume Low-Complexity Outpatient Care: Using Discrete Choice Experiments in Ophthalmology to Improve Diagnostic Service Delivery in England

    Dec 1, 2023, 00:00

  • EE482 Economic Cost of Implementation of a Frailty Care Bundle to Reduce Risk of Hospital Associated Decline Among Older Patients

    Dec 1, 2023, 00:00

  • EE423 The Cost Savings Potential Associated with the Use of Nefecon for Adults with Primary IgA Nephropathy in the United States

    Dec 1, 2023, 00:00

  • EE257 Real-World, Longitudinal, Retrospective Study of Healthcare Resource Utilization of Patients With Atopic Dermatitis Under the Public Health Insurance Plan of Quebec, Canada

    Dec 1, 2023, 00:00

  • PCR166 Regaining Activities of Daily Living After Stroke – What Matters Most for Patients in Neurorehabilitation?

    Dec 1, 2023, 00:00

  • EE214 The Cost-Effectiveness of Abemaciclib Combined With Endocrine Therapy (ET) for the Treatment of Persons With HR+, HER2- Node Positive, Early Breast Cancer (EBC) at High Risk of Recurren A Spanish Healthcare Perspective

    Dec 1, 2023, 00:00

  • HSD52 Employess Satisfaction Level from Working Conditions at the Public Psychiatric Hospital of Athens, Greece

    Dec 1, 2023, 00:00

  • PCR53 To What Extent European Value-Based Pricing Methodologies Take Into Account Patient Perspectives and Broader Societal Benefits?

    Dec 1, 2023, 00:00

  • EE141 Budget Impact Model for the Swiss Healthcare System: Assessing Potential Budget Savings of an Adapted Fall-2023-COVID-19 Vaccination Strategy

    Dec 1, 2023, 00:00

  • MSR13 Formulating Bayesian Poly-Hazard Models for Informed and Clinically Interpretable Lifetime Survival Extrapolations in Advanced Non-Small Cell Lung Cancer (aNSCLC)

    Dec 1, 2023, 00:00

  • HSD56 Utilization of Vascular Assessment Before Lower Extremity Amputation Among Patients With Diabetic Foot Ulcerations in the US

    Dec 1, 2023, 00:00

  • EE698 A Systematic Literature Review of Economic Evaluations in Primary Biliary Cholangitis

    Dec 1, 2023, 00:00

  • HSD33 Horizontal Inequities in the Healthcare Expenditures for Communicable Disease: An Evidence from the National Sample Survey Data

    Dec 1, 2023, 00:00

  • HTA206 How Do the Stricter Pricing Regulations of the Statutory Health Insurance Financial Stabilization Act (GKV-FINSTG) Affect Reimbursement Prices of New Drugs in Germany?

    Dec 1, 2023, 00:00

  • RWD134 Assessing the Association between Pain Burden and Limitations Among Older United States Adults with Pain who Used Opioids

    Dec 1, 2023, 00:00

  • EE745 Cost- Effectiveness of Pneumococcal Vaccination for Adults Aged 60 Years and Older in Peru

    Dec 1, 2023, 00:00

  • MT74 The Impact of Installing a Rfid Cabinet for the Inventory of Intraocular Lenses As Part of the Cataract Surgery Pathway: A Spanish Public Hospital Perspective

    Dec 1, 2023, 00:00

  • SA22 Tepotinib Versus Chemotherapy in Met Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC): Real-World Evidence (RWE) and Matching-Adjusted Indirect Comparison (MAIC) to Explore the Impact of Subsequent Therapy

    Dec 1, 2023, 00:00

  • EE45 Differing Approaches to the Health Economic Investigation of the Informal Care of People Living With Multiple Sclerosis: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • EPH257 Healthcare Resource Consumptions of Patients with Atopic Dermatitis through Italian Administrative Healthcare Data

    Dec 1, 2023, 00:00

  • RWD42 Stoma-Related Outcomes and Costs Associated with Initial Stoma Product Selection – Findings from a Swedish Register and Chart Review Study

    Dec 1, 2023, 00:00

  • PCR43 A Review of Migraine-Related Pros in FDA Labelling Claims (2018-2023)

    Dec 1, 2023, 00:00

  • EE55 Cost-Effectiveness of ESMO-Recommended Lenvatinib and Pembrolizumab Regimen as Second-Line Treatment for Advanced Endometrial Carcinoma in Taiwan: A Comparison With NCCN Recommendations

    Dec 1, 2023, 00:00

  • HPR109 What Drives Socially Acceptable Costs in Outcomes Based Agreements? a Survey Studying Gene Therapies

    Dec 1, 2023, 00:00

  • RWD37 Pre-/Post Prevalence of Cardiovascular Diseases in Hospitalized COVID Patients: A German Claims Data Analysis

    Dec 1, 2023, 00:00

  • EE44 Health Care Resource Utilization and Cost in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada

    Dec 1, 2023, 00:00

  • CO104 Identification and Selection of Biomarkers in Patient-Centric Treatment Management of Rare/Orphan Kidney Diseases: An Ongoing Research Project Aiming to Develop Personalized Treatment Algorithms

    Dec 1, 2023, 00:00

  • EE109 Healthcare Resource Utilization Among Patients with Transfusion-Dependent Beta-Thalassemia in France

    Dec 1, 2023, 00:00

  • SA66 Expert Elicitation Techniques: Informing Application in HTA Decision-Making

    Dec 1, 2023, 00:00

  • CO34 Mortality and Clinical Complications Among Patients with Transfusion-Dependent Beta-Thalassemia in France

    Dec 1, 2023, 00:00

  • SA44 Clinical Burden of Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Focused Literature Review

    Dec 1, 2023, 00:00

  • EE466 Economic Evaluation of Improving Medication Adherences for Secondary Cardiovascular Disease Prevention: A Threshold Analysis

    Dec 1, 2023, 00:00

  • EE529 Methodology for the Monetization of Vial Remnants in the Aseptic Unit

    Dec 1, 2023, 00:00

  • EE647 Excess Healthcare Resource Use Among Subgroups With Anxiety and Depressive Symptoms in Hungary

    Dec 1, 2023, 00:00

  • HPR2 Baseline Characteristics of Patients Applying for Reimbursment of Liraglutide (Saxenda®) for Weight Management Under a Managed Access Protocol in Ireland

    Dec 1, 2023, 00:00

  • EE476 Cost Analysis of Patiromer Versus Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia in the UK, Italy and Spain

    Dec 1, 2023, 00:00

  • HTA20 Predicting Post-AMNOG Price for a New Product Launch in Germany

    Dec 1, 2023, 00:00

  • MSR138 On When and How to Use External Data to Inform Long-Term Survival Curve Extrapolation

    Dec 1, 2023, 00:00

  • EE17 Societal Burden of Non-Alcoholic Steatohepatitis (NASH) in Denmark - Real-World Evidence from National Registries

    Dec 1, 2023, 00:00

  • EE638 Cost-Effectiveness of Vasopressin Alone or in Combination With SOC in the Treatment of Sepsis and Septic Shock Patients

    Dec 1, 2023, 00:00

  • PCR192 Content Validity of the EQ-5D and Health Utilities Index (HUI) to Assess Health-Related Quality-of-Life (HRQoL) Impact in Duchenne Muscular Dystrophy (DMD)

    Dec 1, 2023, 00:00

  • PCR186 Patient Engagement in Real-World Data Collection: User Characteristics of a Health App for People Living With Pancreatic Cancer

    Dec 1, 2023, 00:00

  • EE454 What Is the Goal of Value-Based Pricing, and to Whom Is Value Created?

    Dec 1, 2023, 00:00

  • The Impact of Cost-Containment Initiatives from across the Globe

    Dec 1, 2023, 00:00

  • EE12 An Economic Model Comparing Fever Management to Fever Prevention With Advanced Targeted Temperature Management (ATTM) in Out-of-Hospital Cardiac Arrest (OHCA) Patients

    Dec 1, 2023, 00:00

  • EE557 Economic Burden of Cystic Fibrosis in Five Key European Countries: A Systematic Review

    Dec 1, 2023, 00:00

  • MT79 This Technology Should be Compared With? And Who for? The Digital Health Population Conundrum

    Dec 1, 2023, 00:00

  • HTA92 A Targeted Review of Methods for Effect Modifier (EM) and Prognostic Factor Identification in Population Adjusted Indirect Comparisons (PAICs) in NICE Oncology Submissions

    Dec 1, 2023, 00:00

  • CO160 Burden of Illness and Treatment Patterns of Adult Patients with Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • HTA131 Cost-Effectiveness Threshold in Denmark's New Health Technology Assessment Process: What Do We Know so Far?

    Dec 1, 2023, 00:00

  • PCR112 Characteristics of Individuals Living with Obesity in Germany, Weight-Loss Methods Attempted and Healthcare Resource Use over a 12-Month Period

    Dec 1, 2023, 00:00

  • EPH137 Healthcare Resource Consumption and Direct Costs of Patients Newly Diagnosed with Acute Myeloid Leukemia from a Large Italian Administrative Database

    Dec 1, 2023, 00:00

  • EE332 Evaluation of Hospital Pandemic Control Strategies of a Chinese Tertiary Care Hospital During the Late Phase of COVID-19 Pandemic

    Dec 1, 2023, 00:00

  • HTA8 Health Technology Assessment (HTA) Case Studies: Comparing Acceptability of Real-World Evidence (RWE) in Appraisals for Oncology Medicines

    Dec 1, 2023, 00:00

  • CO140 Drivers of Physicians’ Treatment Decision-Making and Future Treatment Expectations: Analysis of the Adelphi Real-World Ovarian Cancer II Disease Specific Programme (DSPTM)

    Dec 1, 2023, 00:00

  • HSD63 New Pathway in Anti-HER2 Treatments’ Administration in Breast Cancer in Fran Which Impacts of the Involvement of an Advanced Practice Nurse in Hospital at Home Program?

    Dec 1, 2023, 00:00

  • EE400 Cost-Effectiveness of Cannabidiol (CBD) for the Treatment of Seizures in Patients with Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands

    Dec 1, 2023, 00:00

  • EPH79 Epidemiology of Systemic Mastocytosis (SM) and Indolent Systemic Mastocytosis (ISM) in Germany

    Dec 1, 2023, 00:00

  • RWD110 Lifetime Costs of Stroke in Brazil with a Focus on Hemorrhagic Subtypes

    Dec 1, 2023, 00:00

  • RWD158 Estimates on Waste of Breast Cancer Related Chemotherapy Drugs in the NHS (ENGLAND)

    Dec 1, 2023, 00:00

  • EE599 Selection of Post-Patient Death Caregiver and Family Utilities When Estimating Spillover Effects

    Dec 1, 2023, 00:00

  • EE480 Cost-Effectiveness Analysis of an Implantable Device for Chronic Gastro-Oesophageal Reflux Disease in Sweden

    Dec 1, 2023, 00:00

  • EPH208 Adoption of Precision Health (PH) and Precision Medicine (PM) Approaches in Addressing Population Health Needs in Europe

    Dec 1, 2023, 00:00

  • HPR144 Support of RWE in the Price and Reimbursement Decision-Making Process for Rare Diseases in Spain

    Dec 1, 2023, 00:00

  • HPR117 Underinvestment in Poland and Its Impact on Health Outcomes

    Dec 1, 2023, 00:00

  • P27 How Untruthfulness in Self-Reported Medication Adherence Influences Treatment Preferences: A Discrete Choice Experiment

    Dec 1, 2023, 00:00

  • MSR149 Cost-Effectiveness Model Conceptualisation in Chronic Graft Versus Host Disease

    Dec 1, 2023, 00:00

  • HTA257 Key HTA Learnings from Approved Gene Therapies Across the EU4, England, and the US

    Dec 1, 2023, 00:00

  • EE515 Economical Impact of Dose Reduction Treatment for Ribociclib, Palbociclib and Abemaciclib in Colombia

    Dec 1, 2023, 00:00

  • EPH225 The Shifting Patterns of Childhood Obesity: Insights from Population-Based Data

    Dec 1, 2023, 00:00

  • EPH107 Predictors and Consequences of Pediatric Nurses' Burnout: An Integrative Review

    Dec 1, 2023, 00:00

  • EE271 Cost-Effectiveness of Finerenone in Addition to Standard-of-Care in Treating Type 2 Diabetes and Chronic Kidney Disease in China

    Dec 1, 2023, 00:00

  • EPH134 Prevalence of and Associated Factors for Therapy Delay Due to COVID-19 Pandemic Among Breast Cancer Patients in Europe

    Dec 1, 2023, 00:00

  • CO95 Matching-Adjusted Indirect Comparison (MAIC) in Previously Treated KRAS G12C-Mutated Advanced/Metastatic Non-Small Cell Lung Cancer (a/mNSCLC): Adagrasib Versus Sotorasib

    Dec 1, 2023, 00:00

  • EE429 Current Parallel Trade Practice in the Pharmaceutical Industry Focusing on European Single Market, Utilizing a Cost-Saving Analysis in the Allergen Immunotherapy Market of Germany

    Dec 1, 2023, 00:00

  • EE669 Quality of Life and Economic Burden of Advanced Non-Small Cell Lung Cancer in Medium and Small Markets (MEDSM): A Systematic Literature Review

    Dec 1, 2023, 00:00

  • PCR163 Modification of the Social Ecological Model to Distinguish the Terms “HRQoL” and “QoL” in Patient-Centered Outcomes Research

    Dec 1, 2023, 00:00

  • PCR176 Establishing the Interchangeability Between CSF and PET to Identify Patients With Alzheimer's Disease Pathology

    Dec 1, 2023, 00:00

  • PCR208 Pace CKD Financial Burden and Work Productivity Assessment of Chronic Kidney Disease on Patients: Results from an International Survey

    Dec 1, 2023, 00:00

  • RWD23 Comparison of the Use of Real-World Evidence (RWE) by Health Technology Assessment (HTA) Agencies in Reviews of Drugs for Rare Diseases (DRDS)

    Dec 1, 2023, 00:00

  • HTA232 A Multi-Criteria Decision Analysis Framework for the Value Assessment of First-Line Treatment of Adult Patients with Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • HTA35 G-BA Vs. InEK: Navigating Divergent Requirements Between the Two Key Bodies Behind Inpatient Drug Reimbursement in Germany

    Dec 1, 2023, 00:00

  • HTA251 Unraveling the Relationship between Expedited Regulatory Approval By the European Medicines Agency (EMA) and Reimbursement Outcomes for Drugs Approved Under Exceptional Circumstances

    Dec 1, 2023, 00:00

  • HTA200 Review of Population-Adjusted Indirect Treatment Comparison Methods in NICE Non-Oncology Appraisals

    Dec 1, 2023, 00:00

  • HTA33 Are Digital Health Therapeutics Reshaping the HTA Framework for Health Technologies?

    Dec 1, 2023, 00:00

  • EE64 Change in Healthcare Resource Use and Associated Costs of Patients with Metastatic Lung Cancer between 2013 and 2019: An Observational Study from the French National Claims Database

    Dec 1, 2023, 00:00

  • EE532 A Conceptual Model for the Cost Effectiveness of Artificial Intelligence-Assisted Chest Computed Tomography (CT) to Detect Lung Nodules and Improve Decision Making

    Dec 1, 2023, 00:00

  • PCR265 A Core Outcome Set for the Evaluation of New Healthcare Programs in Sweden

    Dec 1, 2023, 00:00

  • CO139 Acalabrutinib (AKA) Versus Venetoclax With Obinutuzumab (VEN+OBI) in Patients With Untreated Chronic Lymphocytic Leukemia (CLL) and Unmutated IGHV Genes – Indirect Comparison

    Dec 1, 2023, 00:00

  • MSR102 Advancing Causal Inference With Machine Learning and Real-World Data: An Application of Targeted Machine Learning and Super Learners on Hospital-Acquired Pressure Injuries From MIMIC IV

    Dec 1, 2023, 00:00

  • MSR63 Implementing Simple Active Learning (AL) Boosters Considerably Improves the Early Identification of Relevant Studies in the Systematic Literature Review (SLR) Process

    Dec 1, 2023, 00:00

  • HPR130 Analysis of Extemporaneous Compounding of Medicines During COVID-19 and Wartime in Ukraine

    Dec 1, 2023, 00:00

  • EE42 Comparison of Cost of Incident Rheumatoid Arthritis Patients in Turkey with Selected European Countries

    Dec 1, 2023, 00:00

  • HPR135 The Need for Novel Mechanisms to Tackle the Global Antimicrobial Resistance (AMR) Threat: Are Innovative Payment Models Enough?

    Dec 1, 2023, 00:00

  • EPH7 Estimating the Projected Impact of Weight Loss on Obesity Prevalence and Healthcare Costs in a UK Population

    Dec 1, 2023, 00:00

  • MT31 The Promising Future of Digital Health: A Road to Reimbursement in US EU5 Markets?

    Dec 1, 2023, 00:00

  • CO106 A Structured Expert Elicitation Exercise Conducted With UK Clinicians to Inform and Validate Inputs for a Cost-Effectiveness Analysis of FILSUVEZ® Gel (Birch Bark Extract) in Epidermolysis Bullosa

    Dec 1, 2023, 00:00

  • EE568 Does the Introduction of an Infliximab Biosimilar Always Result in Savings for Hospitals? A Descriptive Study Using Real-World Data

    Dec 1, 2023, 00:00

  • EE370 Cost-Effectiveness Analysis of Pembrolizumab as Adjuvant Treatment for Resected Stage IIB/IIC Melanoma in Greece

    Dec 1, 2023, 00:00

  • PCR256 Correlation of Patient-Reported Vitiligo Noticeability Scale With Physician-Assessed Facial Vitiligo Area Scoring Index Responses: Post Hoc Analyses From the True-V Trials of Ruxolitinib Cream in Vitiligo

    Dec 1, 2023, 00:00

  • EPH231 The Impact of COVID-19 on National Disease Dynamics: Population-Based Interrupted Time Series Study in South Korea

    Dec 1, 2023, 00:00

  • EPH159 Evaluation of Invasive Pneumococcal Disease and Pneumococcal Vaccination Coverage in a Hospital of Spain

    Dec 1, 2023, 00:00

  • MSR145 Identifying Effect of a Treatment from Observational Data in Absence of Contemporaneous Control: Example of the French Study Tosca, Comparing Cemiplimab Vs. Historical Systemic Treatment in Cutaneous Squamous Cell Carcinoma

    Dec 1, 2023, 00:00

  • HTA183 Setting the Right Discount Rate for Health Technology Assessment in the Slovak Republic

    Dec 1, 2023, 00:00

  • HTA271 Shifting Landscape of Indirect Comparison Methodologies and Their Role in Informing NICE Decision-Making Processes

    Dec 1, 2023, 00:00

  • HTA224 Improving Access to Behavioral and Mental Health Therapies in the EU: An Analogue Assessment Deep Dive

    Dec 1, 2023, 00:00

  • PCR69 Understanding Determinants of the Burden Experienced by Informal Caregivers of Myasthenia Gravis Patients

    Dec 1, 2023, 00:00

  • P51 Testing a Survival Extrapolation Algorithm for Cancer Immunotherapies: Pass or Fail?

    Dec 1, 2023, 00:00

  • EE501 Impact of Eptinezumab on Healthcare Resource Utilization in Patients with Migraine in the United States: A Retrospective Cohort Claims Database Study

    Dec 1, 2023, 00:00

  • HPR124 Opportunities for Improving Healthcare for Migrant Populations, as Identified by Healthcare Teams in Various Regions of Chile

    Dec 1, 2023, 00:00

  • PCR243 Psychometric Validation of QlQ-OES18 in 2L Esophageal Squamous Cell Cancer (ESCC) Patients Treated with Tislelizumab Versus Chemotherapy

    Dec 1, 2023, 00:00

  • EE716 Resource Utilisation and Healthcare Costs Among Patients with Age-Related Macular Degeneration (NAMD) in Italy: Findings from the Radiance Observational Substudy

    Dec 1, 2023, 00:00

  • MT40 Trends of Use of Knotless Tissue Control Devices and Smooth Sutures in Robotic Ventral Hernia Repair: A Retrospective Database Analysis

    Dec 1, 2023, 00:00

  • EE348 The Economic Burden of Multiple Sclerosis in an Italian Cohort of Patients: Analysis of Disease Cost and Its Components

    Dec 1, 2023, 00:00

  • RWD153 Economic and Humanistic Burden Among Patients With Non-Radiographic Axial Spondyloarthritis in China

    Dec 1, 2023, 00:00

  • HTA303 Are BSC and Patient-Individual Therapy as Appropriate Comparators Detrimental for AMNOG Benefit Assessment and Price Rebates in Germany?

    Dec 1, 2023, 00:00

  • SA15 A Systematic Review to Assess How Cure Is Modelled and Subsequently Evaluated in Health Technology Submissions to the National Institute for Health and Care Excellence (NICE)

    Dec 1, 2023, 00:00

  • RWD32 Hearing the Patient Voice in Japan – Utilisation of Patient-Reported Outcomes and Wearable Device Data for Patient-Centric Real-World Research

    Dec 1, 2023, 00:00

  • MSR136 IPECAD Modeling Workshop 2023 Cross Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease and Related Dementias

    Dec 1, 2023, 00:00

  • EPH38 Exploring the Relationship Between Hemochromatosis and Fracture Risk: A Population-Based Matched Cohort Study Stratified on Ferritin Levels

    Dec 1, 2023, 00:00

  • HPR96 Pieces: Productivity Losses Due to Premature Mortality From Cancer in Greece

    Dec 1, 2023, 00:00

  • EE524 Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for High-Risk Early-Stage Triple Negative Breast Cancer in Costa Rica

    Dec 1, 2023, 00:00

  • EPH73 Modelling the Wider Socio-Economic Costs of Problematic Opioid Use in Germany

    Dec 1, 2023, 00:00

  • OP18 Are We Ready for a Digital Transformation in HEOR and Market Access?

    Dec 1, 2023, 00:00

  • EPH144 Annual Health Insurance Treatment Cost of Female Infertility, Unspecified Based on Routinely Collected Financing Data Between 2010-2019

    Dec 1, 2023, 00:00

  • EE525 Cost Effectiveness of the Chimeric Antigen Receptor (CAR) T Cell Treatment Lisocabtagene Maraleucel (Liso-Cel) As Second-Line (2L) Treatment of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) in Switzerland

    Dec 1, 2023, 00:00

  • EE96 Resource Consumption Analysis in Patients with Hemophilia A Without Inhibitors on Prophylaxis with FVIII Before Switching to Emicizumab

    Dec 1, 2023, 00:00

  • MT65 Systematic Review of the Health-Economic Impact of Diagnostic Modality Selection for Patients with Coronary Artery Disease

    Dec 1, 2023, 00:00

  • HSD91 High Costs, Low Quality of Life, Reduced Survival, and Room for Improving Treatment: An Analysis of Burden and Unmet Needs in Glioma

    Dec 1, 2023, 00:00

  • HTA176 Feasibility of Cervical Cancer Screening Policy Using Self-Collected Samples for HPV DNA Testing in Thailand

    Dec 1, 2023, 00:00

  • HSD23 Health Technology Management - The Future of the Post-Reimbursement Phase?

    Dec 1, 2023, 00:00

  • PCR234 The Burden of Migraine in Czech Republic: Patient, Payer, and Societal Perspective

    Dec 1, 2023, 00:00

  • HPR143 Standardizing Cross-Border Access to Advanced Therapies

    Dec 1, 2023, 00:00

  • EPH171 Clinical, Economic, and Patient-Reported Impact of Obesity in the Asia-Pacific Region: A Systematic Review

    Dec 1, 2023, 00:00

  • PCR248 Meaningful Within-Patient Change Threshold Range for the FACIT-Fatigue in Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Dec 1, 2023, 00:00

  • RWD181 Improving Clinical Practice and Patient-Centric Care through Digital Outcome Measurement Tools

    Dec 1, 2023, 00:00

  • HTA263 NICE Listens: Engaging the Public on How Environmental Sustainability Should Be Considered in Health Technology Assessment and Guideline Development

    Dec 1, 2023, 00:00

  • EE578 Estimating Economic Impact of Fenofibrate Among Patients with Diabetic Retinopathy in China

    Dec 1, 2023, 00:00

  • PCR89 Predicting EQ-5D-5L Score by Using SGRQ in Patients with Asthma and/or COPD in NOVELTY

    Dec 1, 2023, 00:00

  • CO49 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Ixekizumab at 52 Weeks for the Treatment of Radiographic Axial Spondyloarthritis

    Dec 1, 2023, 00:00

  • EE26 Deprescribing of Proton Pump Inhibitors in Elderly Patients: A Cost-Effectiveness Analysis

    Dec 1, 2023, 00:00

  • HTA228 Can Just Three PICOs be Feasible for Oncology Assessments with the Joint EU HTA Framework, Whilst Considering All 27 Member States Specificities?

    Dec 1, 2023, 00:00

  • EE447 Working With Probabilistic Models for Cost-Effectiveness Analysis: Computational Tools Integrating Exact Methods vs Simulation-Based Approaches

    Dec 1, 2023, 00:00

  • HTA265 Development of the Reliant Checklist to Support the HTA Deliberation

    Dec 1, 2023, 00:00

  • HSD88 The Propensity to Receive Haematopoietic Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma Patients Based on Sex, Ethnicity, and Deprivation: Results From National Cancer Registry Linked Real-World Datasets in England

    Dec 1, 2023, 00:00

  • RWD79 Impact of Google Searches on Suicide Rates in Colombia

    Dec 1, 2023, 00:00

  • HPR43 Are There Any Common Denominators for Early Access Programs in Europe?

    Dec 1, 2023, 00:00

  • EE323 Cost Comparison Analysis of Patiromer Versus Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia in Saudi Arabia

    Dec 1, 2023, 00:00

  • HSD69 Maternal and Foeto-Neonatal Characteristics of Childbirths in Ethiopia: A Multilevel Mixed-Effect Analysis

    Dec 1, 2023, 00:00

  • EE295 Willingness to Pay for COVID-19 Vaccines in Hungary

    Dec 1, 2023, 00:00

  • HTA70 The Italian Healthcare System Competences in View of the New European HTA Regulation

    Dec 1, 2023, 00:00

  • HPR93 Impact of Generic Competition on Prices, Public Spending and Utilization of Antiepileptic Medicines in Bulgaria

    Dec 1, 2023, 00:00

  • P2 NICE's Pathways Pilot: Incorporating Disease-Specific Reference Models Into Health Technology Assessment in England

    Dec 1, 2023, 00:00

  • PCR30 Benefits and Challenges of Different Qualitative Approaches in Rare Disease: A Case Study in Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Using a Narrative Exercise and Qualitative Interviews

    Dec 1, 2023, 00:00

  • HTA332 Evaluating Transcatheter Valve Replacement in Tricuspid Regurgitation: Complexities and Limitations of Existing Models

    Dec 1, 2023, 00:00

  • HTA291 How Are Patients Involved in Health Technology Assessment? A Comparative Analysis of European Markets for Advanced Therapies and Implications for Joint Clinical Assessment

    Dec 1, 2023, 00:00

  • EE434 Analysis of the Clinical and Economic Impact of High Protein Concentration Ons in a Spanish Hospital Setting

    Dec 1, 2023, 00:00

  • HSD46 Multidisciplinary Discussion for Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: A Cross Sectional Survey to Evaluate the Experiences of Multidisciplinary Teams in Italy

    Dec 1, 2023, 00:00

  • RWD162 Evolution of Breast Cancer Treatment Cost in the Last 36 Months: An Analysis From a Health Payer Perspective in Brazil

    Dec 1, 2023, 00:00

  • EE125 Cost Consequences of Using Clevidipine in Acute Hypertension from the Perspective of a US Hospital

    Dec 1, 2023, 00:00

  • EPH151 Prevalence of Risk Factors for Serious Adverse Events Among Rheumatoid Arthritis Patients Prescribed Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors: A Merative Marketscan Cross-Sectional Study

    Dec 1, 2023, 00:00

  • EE637 Economic Impact of Managing Invasive Mold Disease With Isavuconazole Compared With Liposomal Amphotericin B in Spain

    Dec 1, 2023, 00:00

  • PCR97 Impact of Paroxysmal Nocturnal Haemoglobinuria on Employment and Activity: Results from a Real-World Study

    Dec 1, 2023, 00:00

  • EE749 Cost-Effectiveness Analysis of the Pediatric 20-Valent Pneumococcal Conjugate Vaccine Compared to Lower-Valent Alternatives in Argentina

    Dec 1, 2023, 00:00

  • EPH8 Insulin Analogs in Type 1 Diabetes Treatment: An Incorporation Process Study in Brazilian Unified Health System (SUS)

    Dec 1, 2023, 00:00

  • EE530 Global Clinical, Economic, Health-Related Quality of Life Burden, and Treatment Outcomes in Follicular Lymphoma: A Systematic Review

    Dec 1, 2023, 00:00

  • EE575 Economic Analysis of the Costs Associated With Reusable Flexible Ureteroscopes – Implications for the Utilization of Single-Use Digital Flexible Ureteroscopes

    Dec 1, 2023, 00:00

  • HPR102 Factors Influencing Orphan Drug Net Prices in the EU4 and US – Insights from Payers

    Dec 1, 2023, 00:00

  • RWD24 Decision Making and the Questions Raised When Real World Evidence From a Federated Data Network Conflicts With RCT Data: A Use Case on COVID-19 Treatments

    Dec 1, 2023, 00:00

  • EPH77 An Incidence- and Survival-Based Epidemiological Model for the Prevalence of Duchenne Muscular Dystrophy in Nine Countries

    Dec 1, 2023, 00:00

  • EE531 Resource Optimization for Greek NHS Hospitals from the Use of Daratumumab SC for Multiple Myeloma

    Dec 1, 2023, 00:00

  • EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study

    Dec 1, 2023, 00:00

  • EPH68 What Are the Main Symptoms of Long COVID? Real World Medical Data Cross-Referenced with Social Network Content

    Dec 1, 2023, 00:00

  • PCR123 Assessing the Impact of Relapses on Burden to the Patient and Caregiver in NMOSD

    Dec 1, 2023, 00:00

  • MT16 A Review of NICE Submissions for Medical Technologies in the UK: Key Trends over the Last 2 Years

    Dec 1, 2023, 00:00

  • OP5 Multistakeholder Healthcare Cooperative: A New Paradigm for Healthcare Delivery

    Dec 1, 2023, 00:00

  • RWD95 Eosinophilic Granulomatosis with Polyangiitis: Estimation of the Clinical and Economic Burden in Fran A Real-World Retrospective Study Based on the National Health Data System (SNDS)

    Dec 1, 2023, 00:00

  • MSR137 Consideration of Competing Risks in Early Setting in Oncology and Impact on the Survival Estimates: To Explicitly Model Them? An Example of a French Real-World Cohort in Urothelial Carcinoma

    Dec 1, 2023, 00:00

  • HTA130 Different Approaches to the Health Economic Evaluations for the Health Technology Assessment Submissions

    Dec 1, 2023, 00:00

  • PCR27 Association between Health-Related Quality of Life and Requirement for Non-Professional Care in Adults with Rare Diseases: A Real-World Study

    Dec 1, 2023, 00:00

  • EE623 Open Data Available in Fran A Great Asset to Study Real-Life Trends for Disease Burden - An Example With Bariatric Surgery Procedures

    Dec 1, 2023, 00:00

  • EE50 What Is the Economic Impact of an Early Adoption of High Efficacy Treatments in Multiple Sclerosis? A Cost-Consequence Analysis From a Societal Perspective in the Portuguese Setting

    Dec 1, 2023, 00:00

  • HTA336 The Danish Health Technology Council – HTA Organisations As the Nexus between Science and Policy

    Dec 1, 2023, 00:00

  • EE164 Cost-Effectiveness of Inclisiran as Add-on Therapy to Standard-of-Care for the Secondary Prevention of Cardiovascular Events in Patients with Elevated LDL Cholesterol

    Dec 1, 2023, 00:00

  • HSD32 Long COVID: Clinical Characteristics and Management in the Real-World Setting

    Dec 1, 2023, 00:00

  • EE201 Clinical and Economic Consequences of Epilepsy Treatment across Incremental Treatment Lines in Spain: A Real Life Database Analysis

    Dec 1, 2023, 00:00

  • PT25 Comparison of Approval Dates of New Substances Between the United States of America (Food and Drug Administration, FDA) and Europe (European Medicines Agency, EMA)

    Dec 1, 2023, 00:00

  • PT24 Reimbursement Decisions in Ireland; Utilising Text Mining to Assess Factors Contributing to Decision Making

    Dec 1, 2023, 00:00

  • SA50 Economic Evaluation of Robotic-Assisted Surgery: Methods, Challenges, and Opportunities

    Dec 1, 2023, 00:00

  • EE694 Evaluation of Healthcare Resource Utilization and Cost Among First-Line Patients Receiving Ibrutinib Vs Acalabrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Commercial Claims Database Analysis

    Dec 1, 2023, 00:00

  • EPH96 Projected Prevalence of Acute, Chronic, and End-Stage Kidney Disease in the UK From 2023 to 2033

    Dec 1, 2023, 00:00

  • MSR143 Extending Bayesian Evidence Synthesis to Include Historical Trial Data for Improved Survival Extrapolations from Early Data Cuts in Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Dec 1, 2023, 00:00

  • MSR99 Application of Artificial Intelligence in Literature Reviews

    Dec 1, 2023, 00:00

  • EPH39 Epidemiology and Patient Characteristics of Pemphigus Vulgaris in Italy Based on Administrative Database

    Dec 1, 2023, 00:00

  • EE585 Threshold Price Analysis of Micro-Hole Zone Technology Catheters Compared to Standard Hydrophilic-Coated Catheters in Long-Term Intermittent Catheter Users in the UK

    Dec 1, 2023, 00:00

  • PCR175 Real-World Impact of Migraine on Canadians’ Productivity: A Pharmacy-Based Study

    Dec 1, 2023, 00:00

  • HTA219 Examining the Awareness and Perceptions of EU HTA Amongst Irish Pharmaceutical Industry Professionals

    Dec 1, 2023, 00:00

  • HTA26 Portuguese Clinical Practice and Costs in the Treatment of Acid Sphingomyelinase Deficiency Disease

    Dec 1, 2023, 00:00

  • CO63 Systematic Literature Review of Health-Related Quality of Life in Advanced or Metastatic Esophageal Cancer

    Dec 1, 2023, 00:00

  • EPH139 A Retrospective Cohort Study of Pediatric Patients Undergoing Percutaneous Vascular Procedures

    Dec 1, 2023, 00:00

  • HTA128 Use of Patient Preference Studies in NICE Submissions in the Last 5 Years

    Dec 1, 2023, 00:00

  • EE661 The Quality of Economic Evaluations of Breast Cancer for Diagnostics, Screening, and Therapeutics in the Middle East: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • HTA80 To What Extent Do the EUnetHTA 21 D4.4 Guidelines on Endpoints Recognize Non-Os Endpoints and Patient-Reported Outcomes, and What Opportunities Exist in the Joint Clinical Assessment to Reflect Their Value?

    Dec 1, 2023, 00:00

  • HTA155 The Impact of Phase 2 Clinical Trials on Reimbursement Recommendations in Oncology By Canadian Health Technology Assessment Agencies

    Dec 1, 2023, 00:00

  • EPH135 Years of Life Lost and Productivity Costs Due to Premature Cancer-Related Mortality in Egypt

    Dec 1, 2023, 00:00

  • PT46 Does Public Research Investment on Emerging Infectious Diseases Correspond to Disease Burden in China? A Cross-Sectional Study from 2009 to 2019

    Dec 1, 2023, 00:00

  • MSR69 Modelling Social and Economic Burden of Hepatits C in Russia in Different Scenarios of Control Measures up to 2035

    Dec 1, 2023, 00:00

  • CO149 Does the EQ-5D Measure the Full Impact of Alopecia Areata on Patients' Health Related Quality of Life?

    Dec 1, 2023, 00:00

  • HTA50 Assessing the Risk of Bias in Clinical Trials for Health Technology Assessments: Should Existing Tools Reflect the ICH E9(R1) Addendum on Estimands and Sensitivity Analyses?

    Dec 1, 2023, 00:00

  • PT7 Data Standardization in Brazil: An OMOP Common Data Model Approach in a DATASUS Cohort

    Dec 1, 2023, 00:00

  • EE401 A Comparison of Health State Occupancy Between Cipaglucosidase Alfa/Miglustat and Alglucosidase Alfa Within a Cost-Effectiveness Modelling Analysis of Late-Onset Pompe Disease

    Dec 1, 2023, 00:00

  • PCR205 Determination of Ranges of HSSDD HSSQ Scores Defining Clinically Meaningful Within-Patient Improvement Thresholds and Severity Levels

    Dec 1, 2023, 00:00

  • RWD106 The Maze of RWE Frameworks: An Environmental Scanning and Comparison Across Regulatory and HTA Bodies

    Dec 1, 2023, 00:00

  • EE590 Assessing Health Outcomes and Cost-Effectiveness of Adult HPV Vaccination in Italy

    Dec 1, 2023, 00:00

  • PCR75 Real-World Evidence of Outcomes of Fulvestrant Monotherapy After Progression on CDK4/6 Inhibitor + Aromatase Inhibitor in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer

    Dec 1, 2023, 00:00

  • CO169 Pan-Stakeholder Core Outcome Set (COS) Definition for Hematological Malignancies in the Framework of the EU Project, Harmony: the Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology

    Dec 1, 2023, 00:00

  • PCR251 Economic and Humanistic Burden of Visual Impairment and Blindness in Patiens and Their Caregivers with Retinitis Pigmentosa or Leber Congenital Amaurosis (E-BIRDS Study)

    Dec 1, 2023, 00:00

  • HPR122 A Conceptual Modeling Framework for Manufacturers to Navigate the Inflation Reduction Act and to Negotiate a “Fair Maximum Price”

    Dec 1, 2023, 00:00

  • PCR266 Transplant Physicians’ Preferences in Deceased Organ Allocation: A Pilot Discrete Choice Experiment

    Dec 1, 2023, 00:00

  • RWD164 The Impact of Spinal Muscular Atrophy (SMA) Type 1 on Caregivers in Taiwan: Results of a Global Survey

    Dec 1, 2023, 00:00

  • RWD51 Application of Real-World Data Sources for Equity-Informed Evaluations of Multiple Myeloma

    Dec 1, 2023, 00:00

  • OP3 Single-Use Vs Reusable Endoscopy Reprocessing: An Efficiency Survey of Nurses and Technicians

    Dec 1, 2023, 00:00

  • SA52 Clinical Impact of Using Digital Healthcare Technology to Manage Diabetes in Adolescents.: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • HTA212 Level of ICER of Health Economic Assessment in France in 2022

    Dec 1, 2023, 00:00

  • HSD19 Evaluation of Vascular Access Modality for Hemodialysis Patients: Analysis of Real-World Data in Italy

    Dec 1, 2023, 00:00

  • EE203 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Other First-Line Therapies for Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer in the United States

    Dec 1, 2023, 00:00

  • HPR18 How Will Recent Pricing Regulations Impact the Global Pricing Landscape?

    Dec 1, 2023, 00:00

  • EE59 Real-Life Costs of Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated by CAR T-Cells in France Between 2017 and 2020 (EpiCART Study)

    Dec 1, 2023, 00:00

  • RWD138 Rising Adoption of Healthcare Wearables in Clinical Study Design

    Dec 1, 2023, 00:00

  • EPH47 Modeling the Impact of the Vaccine Candidate TAK-003 on the Incidence of Dengue in French Overseas Territories

    Dec 1, 2023, 00:00

  • HPR80 Examination of the Changes in the Turkish Pharmaceutical Market between 2007 and 2021

    Dec 1, 2023, 00:00

  • MSR41 Machine Learning and Patient-Reported Outcomes (PROs) in Oncology: A Systematic Literature Review on Methodological Quality

    Dec 1, 2023, 00:00

  • EPH108 Quality of Life of Menopausal Women

    Dec 1, 2023, 00:00

  • PCR23 Patient Preferences for Treatment Attributes and Endpoints in Neoadjuvant Therapy for Early-Stage Breast Cancer

    Dec 1, 2023, 00:00

  • EE753 Cost-Effectiveness Analysis of Fracture Prevention with 25-Hydroxyvitamin D (25(OH)D) Screening Among the Population over 65 Years Old in China

    Dec 1, 2023, 00:00

  • EE468 The Full Circle: Systematic Evaluation, Replication and Validation of Structural Health Economic Modelling Approaches: Lessons Learned in the Field of Obesity

    Dec 1, 2023, 00:00

  • EE189 Combining Causal Inference and Within-Trial Economic Evaluation Methods to Assess the Cost-Effectiveness of a Mental Health Service Using Real-World Data: The Quasi-Experimental Adapt Study

    Dec 1, 2023, 00:00

  • EE219 Lorlatinib as a First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis in Greece

    Dec 1, 2023, 00:00

  • PT2 Comparing UK Value Sets and Mapping Functions for EQ-5D

    Dec 1, 2023, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17 (current)
  • 18
  • 19
  • 20
  • »